162 related articles for article (PubMed ID: 11276021)
1. Clinical significance of E-cadherin expression in thyroid neoplasms.
Naito A; Iwase H; Kuzushima T; Nakamura T; Kobayashi S
J Surg Oncol; 2001 Mar; 76(3):176-80. PubMed ID: 11276021
[TBL] [Abstract][Full Text] [Related]
2. [The expression and clinical significance of EphA2 and E-cadherin in papillary thyroid carcinoma].
Liu Y; Miao Y; Li X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(11):1020-3. PubMed ID: 26536708
[TBL] [Abstract][Full Text] [Related]
3. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue.
Serini G; Trusolino L; Saggiorato E; Cremona O; De Rossi M; Angeli A; Orlandi F; Marchisio PC
J Natl Cancer Inst; 1996 Apr; 88(7):442-9. PubMed ID: 8618236
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.
Mitselou A; Ioachim E; Peschos D; Charalabopoulos K; Michael M; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2007 Mar; 29(1):54-60. PubMed ID: 17431390
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
[TBL] [Abstract][Full Text] [Related]
6. The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.
Montemayor-Garcia C; Hardin H; Guo Z; Larrain C; Buehler D; Asioli S; Chen H; Lloyd RV
Endocr Pathol; 2013 Dec; 24(4):206-12. PubMed ID: 24126800
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin gene alterations are rare events in thyroid tumors.
Soares P; Berx G; van Roy F; Sobrinho-Simões M
Int J Cancer; 1997 Jan; 70(1):32-8. PubMed ID: 8985087
[TBL] [Abstract][Full Text] [Related]
8. [Expression of EpCAM and E-cadherin in papillary thyroid carcinoma and its clinicopathologic significance].
Cheng Y; Meng Y; Liang Z; Yang C; Luo Y; Cui Q
Zhonghua Bing Li Xue Za Zhi; 2015 Mar; 44(3):189-94. PubMed ID: 26268754
[TBL] [Abstract][Full Text] [Related]
9. Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid.
Arai T; Yamashita T; Urano T; Masunaga A; Itoyama S; Itoh K; Shiku H; Sugawara I
Mod Pathol; 1995 Apr; 8(3):252-6. PubMed ID: 7617649
[TBL] [Abstract][Full Text] [Related]
10. [Expression of E-cadherin in thyroid neoplastic tissues and its correlation with malignant and metastatic potential].
Naitoh A; Kobayashi S; Iwase H; Kuzushima T
Nihon Rinsho; 1995 Jul; 53(7):1619-22. PubMed ID: 7629998
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers.
Guo M; Liu C; Qi FJ; Zhang XM; Ren LL; Liu YM; Meng ZC; Zhu ZT; Xiao JY
Asian Pac J Cancer Prev; 2014; 15(17):7425-32. PubMed ID: 25227853
[TBL] [Abstract][Full Text] [Related]
12. Expression and cellular localization of p8 protein in thyroid neoplasms.
Ito Y; Yoshida H; Motoo Y; Miyoshi E; Iovanna JL; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Cancer Lett; 2003 Nov; 201(2):237-44. PubMed ID: 14607339
[TBL] [Abstract][Full Text] [Related]
13. Dysadherin: expression and clinical significance in thyroid carcinoma.
Sato H; Ino Y; Miura A; Abe Y; Sakai H; Ito K; Hirohashi S
J Clin Endocrinol Metab; 2003 Sep; 88(9):4407-12. PubMed ID: 12970317
[TBL] [Abstract][Full Text] [Related]
14. Integrins in thyroid tissue: upregulation of alpha2beta1 in anaplastic thyroid carcinoma.
Dahlman T; Grimelius L; Wallin G; Rubin K; Westermark K
Eur J Endocrinol; 1998 Jan; 138(1):104-12. PubMed ID: 9461325
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin: a differentiation marker in thyroid malignancies.
Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
[TBL] [Abstract][Full Text] [Related]
16. Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma.
Erdem H; Gündogdu C; Sipal S
Exp Mol Pathol; 2011 Jun; 90(3):312-7. PubMed ID: 21335003
[TBL] [Abstract][Full Text] [Related]
17. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
[TBL] [Abstract][Full Text] [Related]
18. Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa.
Santos JE; Kalk WJ; Freitas M; Marques Carreira I; Castelo Branco M
BMC Res Notes; 2015 Jul; 8():284. PubMed ID: 26126625
[TBL] [Abstract][Full Text] [Related]
19. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
[TBL] [Abstract][Full Text] [Related]
20. [Expression of cell adhesion molecule (CD44V6) in thyroid tumors and its significance].
Li L; Lin L; Qiu J
Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):677-80. PubMed ID: 11769722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]